Many people who have had viral hepatitis or are currently living with the condition wonder whether they will be able to obtain life insurance, serious illness cover or income protection in Ireland. It is one of the most common questions we receive from our clients.

The good news is that a diagnosis of viral hepatitis does not automatically mean that your insurance application will be declined. In practice, the outcome depends on the type of virus, the course of the illness, the treatment received and your current state of health.

The term viral hepatitis refers to several different infections caused by viruses that attack the liver. The most common types are hepatitis A, B and C, although hepatitis D and E also exist. Each type differs in the way it is transmitted, the way it affects the body and its long-term health consequences. For this reason, insurers assess each type differently.

The mildest form is hepatitis A (HAV). Infection usually occurs through contaminated food or water or through close contact with an infected person. Hepatitis A does not become a chronic condition, and most people make a full recovery without permanent liver damage. As a result, a previous hepatitis A infection will not usually affect your ability to obtain insurance, provided you have fully recovered and your liver function tests are normal.

The situation is different with hepatitis B (HBV). The virus is mainly transmitted through contact with infected blood, sexual contact or from mother to baby during childbirth. In some people, the infection becomes chronic and may eventually lead to liver fibrosis, cirrhosis or even liver cancer. For this reason, when assessing an insurance application, the insurer will consider factors such as whether the virus is active, your liver function test results, any treatment received and the extent of any liver damage. Depending on these findings, the insurer may offer standard terms, apply a premium loading, postpone the decision or, in more advanced cases, decline the application.

The greatest number of questions relates to hepatitis C (HCV). Until relatively recently, a diagnosis of hepatitis C often made obtaining insurance very difficult. Today, the situation has changed significantly. Thanks to modern antiviral treatments, more than 95% of patients can now be successfully cured. As a result, many insurers in Ireland assess people who have completed successful treatment much more favourably than they did in the past. When reviewing an application, the most important considerations are whether treatment has been successful, whether the virus is undetectable in the blood, whether there is any permanent liver damage and what the current test results show. Many people who have successfully completed treatment are able to obtain insurance, although every application is assessed individually.

Hepatitis D (HDV) is much less common and can only occur in people who are already infected with hepatitis B. Because it is associated with a more severe course of disease, it usually requires a more detailed medical assessment before an insurance decision can be made.

Hepatitis E (HEV) generally has a similar course to hepatitis A. It is more common in countries with lower sanitation standards and, once the person has fully recovered, it usually has little or no impact on their ability to obtain insurance.

When applying for insurance in Ireland, the insurer may request additional medical information. This often includes liver function test results, details of any treatment received, a report from your GP or specialist, and sometimes imaging results such as an ultrasound scan or Fibro Scan. The purpose is not to find a reason to decline the application, but to carry out a fair and accurate assessment of your health risk.

It is also worth remembering that the impact of viral hepatitis may differ depending on the type of insurance you are applying for. A person may qualify for standard life insurance, while income protection or serious illness cover may require a more detailed medical assessment or additional underwriting terms.

It is extremely important to answer all medical questions on your application honestly and accurately. Failing to disclose a previous or current diagnosis of viral hepatitis could have serious consequences and may affect the payment of a future claim.

The best chance of receiving a favourable underwriting decision is for applicants who can provide up-to-date medical test results, documentation confirming successful treatment and evidence of regular medical follow-up. Having complete medical records often speeds up the underwriting process and increases the likelihood of a positive outcome.

Finally, it is important to remember that having had viral hepatitis does not automatically prevent you from obtaining insurance. Advances in modern medicine—particularly in the treatment of hepatitis C—have dramatically improved patient outcomes, and insurers increasingly take these advances into account when assessing applications. Every case is unique, however, so before applying it is worth speaking to an experienced insurance adviser who can help you find the insurer best suited to your individual medical circumstances.

This article is intended for general information purposes only. It does not constitute medical advice or a guarantee that insurance cover will be offered. Every insurance application is assessed individually by the insurer in accordance with its underwriting guidelines.